Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Ordinary Shares, par value $0.0001 per share
-
Shares outstanding
-
134M
-
Number of holders
-
28
-
Total 13F shares, excl. options
-
7.56M
-
Shares change
-
+644K
-
Total reported value, excl. options
-
$23.4M
-
Value change
-
+$1.99M
-
Number of buys
-
11
-
Number of sells
-
-11
-
Price
-
$3.10
Significant Holders of Global Cord Blood Corp - Ordinary Shares, par value $0.0001 per share (CORBF) as of Q2 2020
30 filings reported holding CORBF - Global Cord Blood Corp - Ordinary Shares, par value $0.0001 per share as of Q2 2020.
Global Cord Blood Corp - Ordinary Shares, par value $0.0001 per share (CORBF) has 28 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7.56M shares
of 134M outstanding shares and own 5.65% of the company stock.
Largest 10 shareholders include RENAISSANCE TECHNOLOGIES LLC (3.82M shares), Rock Springs Capital Management LP (925K shares), Oasis Management Co Ltd. (726K shares), Man Group plc (611K shares), Quinn Opportunity Partners LLC (267K shares), ARROWSTREET CAPITAL, LIMITED PARTNERSHIP (229K shares), MORGAN STANLEY (211K shares), NORGES BANK (194K shares), BANK OF AMERICA CORP /DE/ (86.8K shares), and Parametric Portfolio Associates LLC (77.7K shares).
This table shows the top 28 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.